NasdaqGM:BBNXMedical Equipment
Beta Bionics (BBNX) Q1 Loss Of US$21.9 Million Reinforces Bearish Profitability Concerns
Beta Bionics (BBNX) has opened Q1 2026 with revenue of US$27.6 million and a basic EPS loss of US$0.49, alongside a trailing twelve month revenue base of US$110.2 million and a basic EPS loss of US$1.51. Over recent quarters the company has seen revenue move from US$17.6 million in Q1 2025 to US$32.1 million in Q4 2025 and then to US$27.6 million in Q1 2026, while quarterly basic EPS losses ranged between US$0.30 and US$0.93 over that period. This context may lead investors to focus on how...